RESP® Biosensor
Transforming respiratory care and research with real-world insights on lung sounds
Continuous Auscultation:
Novel Insights into Lung Health
Traditional auscultation with a stethoscope has been the gold standard for assessing lung health for over a century, with abnormal events, such as cough, wheezing, rhonchi, or crackles providing reliable indicators of blockage and other problems of the airways.
As auscultation has been limited to episodic, in-person exams, Strados Labs developed the RESP® Biosensor to extend the temporal and geographic range of stethoscopes, providing clinicians and researchers with unprecedented access to patients’ lung sounds.
Our technology, backed by numerous publications and awards, is used globally to measure treatment response in drug development and research studies as well as in clinical settings to provide greater control and management of chronic respiratory diseases.
The RESP® Biosensor: Technology Overview
- Clinically validated accuracy, with equivalent performance to Littman 3200 stethoscope
- Continuous collection of lung sounds such as cough and wheeze to offer objective data on respiratory status passively and remotely
- Patient-friendly device that reduces burden on patients while improving clinician efficiency
Clients & Partners
Track Patient Progress Objectively and Remotely
Patient reports include accurate, time-stamped data on signs and symptoms such as coughing and wheezing, allowing for greater diagnostics and insight into treatment response.
*Machine learning algorithms not FDA-cleared and for investigational use only
How It Works
An end-to-end solution for remote monitoring of lung health
RESP® Biosensor
Patient adheres device to their chest and device continuously captures lung sounds throughout the day and night
Strados™ Mobile App
Lung sound data collected by the device is transferred to a companion patient mobile app via Bluetooth
Strados™ Cloud
Cloud securely stores data where lung sound events such as cough and wheeze are tracked and trended
RESP® Biosensor Measurements
In addition to cough and lung sounds, onboard accelerometer allows for additional insight into breathing patterns and other quality-of-life parameters.
Cough Monitoring
Lung Sounds
Additional Insights*
*Not FDA cleared and for investigational use only
Clinical Evidence
The value and clinical validation of the RESP Biosensor has been presented at several respiratory conferences including the American Thoracic Society and CHEST.
For Healthcare
Improve surveillance and disease management of respiratory patients from hospital to home
For Research Studies
Gain stronger, objective insight into subject treatment response in drug development and clinical trials
OVERVIEW VIDEO
Learn more about the benefits of Strados Labs’ RESP Biosensor System
RESP® Fills a Gap in the Standard of Care
While standard-of-care approaches such as pulmonary function tests and patient self-reports continue to provide value in patient care and research, each method has limitations that our technology addresses to provide the most complete respiratory picture for clinicians and drug developers.
| RESP® Biosensor | Episodic Auscultation | Pulmonary Function Tests | Patient Self-Reporting | Cough Monitors | |
|---|---|---|---|---|---|
| Continuous | |||||
| Objective Data | |||||
| Passive (no patient effort required) | |||||
| Comprehensive Insights | |||||
| Patient-Friendly |
Frequently Asked Questions (FAQ)
Is the RESP® Biosensor reimbursable?
The RESP® Biosensor is reimbursable under RPM and RTM codes.
Is the RESP® Biosensor designed for continuous long-term monitoring?
Yes. The RESP® Biosensor was designed for long-term, continuous remote monitoring with the goal of detecting changes in lung sounds passively ranging from 4 – 24 hours per day.
Which care settings is the RESP® Biosensor intended for?
The RESP® Biosensor is designed to be used across multiple care settings, including in-patient, transitional care, post-acute discharge, outpatient, pulmonary rehabilitation and hospital-at-home. The device is also used in drug development to measure treatment response in clinical trials.